NCT03562273
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patient must be deemed an appropriate candidate for breast conserving therapy; Patient must have tumor less than 4cm before surgery
Exclusions: Patients with proven multi-centric carcinoma (tumors) in different quadrants of the breast; Patients with prior radiation therapy to that breast; Patients with skin involvement, regardless of tumor size; Patients with breast implants/tissue expanders or flap reconstruction
https://ClinicalTrials.gov/show/NCT03562273